Grzeszczak W, Kokot F, Zukowska-Szczechowska E
Katedry i Kliniki Nefrologii Slaskiej Akademii Medycznej.
Pol Arch Med Wewn. 1991 Mar;85(3):150-9.
Plasma atrial natriuretic peptide (ANP) in 51 kidney transplant patients (KTP) during acute rejection (AR) was measured. All 51 KTP were divided in 3 groups. In the first group (16 subjects) patients were treated by azathioprine, predinisone and promethazine, in the second group (16 subjects) patients were treated by cyclosporine A and prednisone however in the third group (19 subjects) patients were treated by cyclosporine A, azathioprine and prednisone. Control group contained 15 subjects. ANP levels in KTP were measured four times: First time nearly 3 days before AR, second time immediately after recognition AR, third time after 3 days methylprednisone therapy and 4th time 3 days after stopping methylprednisone therapy. In all KTP before rejection ANP levels were slightly enhanced. During AR was observed statistically significant increase ANP levels in all KTP. After methylprednisone therapy plasma ANP level returned to basal (before rejection) level. Only before rejection a significant positive correlation was found between ANP and kidney function. All our result suggests participation of factors other than wicked kidney function in the pathogenesis enhanced ANP levels during AR. Kind of immunosuppressive therapy seems only a slightly influence on ANP levels in KTP before and after AR.
对51例肾移植患者(KTP)在急性排斥反应(AR)期间的血浆心房利钠肽(ANP)进行了测定。所有51例KTP患者被分为3组。第一组(16名受试者)患者接受硫唑嘌呤、泼尼松和异丙嗪治疗,第二组(16名受试者)患者接受环孢素A和泼尼松治疗,而第三组(19名受试者)患者接受环孢素A、硫唑嘌呤和泼尼松治疗。对照组包含15名受试者。对KTP患者的ANP水平进行了4次测量:第一次在AR发生前近3天,第二次在识别出AR后立即进行,第三次在甲基泼尼松治疗3天后,第四次在停止甲基泼尼松治疗3天后。在所有KTP患者中,排斥反应前ANP水平略有升高。在AR期间,观察到所有KTP患者的ANP水平有统计学意义的升高。甲基泼尼松治疗后,血浆ANP水平恢复到基础(排斥反应前)水平。仅在排斥反应前,发现ANP与肾功能之间存在显著正相关。我们所有的结果表明,在AR期间ANP水平升高的发病机制中,除了肾功能不良之外,还有其他因素参与。免疫抑制治疗的类型似乎对AR前后KTP患者的ANP水平只有轻微影响。